Bank Julius Baer & Co
HELP

Bank Julius Baer & Co’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bank Julius Baer & Co’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$2K – 635
2021
Q4 		$2K Buy
50
+36
+257% +$2.28K ﹤0.01% 817
2021
Q3 		$2K Buy
+14
New +$1.23K ﹤0.01% 803

Other funds holding HELP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCC
Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
T
TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Bank Julius Baer & Co's HELP Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2022, closing a stake of 50 shares — an estimated $2K sold.

Bank Julius Baer & Co first reported a position in HELP in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 51 funds tracked by Wall St. Rank hold HELP as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 50 Helus Pharma Inc. Common Stock shares in Q1 2022, an estimated $2K.
  • Bank Julius Baer & Co first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Bank Julius Baer & Co's Helus Pharma Inc. Common Stock position peaked at $2K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.